Endurant Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-25,081
| Closed | -$1.15M | – | 70 |
|
|
2018
Q3 | $1.15M | Sell |
25,081
-15,707
| -39% | -$720K | 0.51% | 43 |
|
|
2018
Q2 | $2.41M | Buy |
40,788
+16,088
| +65% | +$952K | 1.05% | 26 |
|
|
2018
Q1 | $1.68M | Sell |
24,700
-5,200
| -17% | -$354K | 0.63% | 40 |
|
|
2017
Q4 | $2.96M | Buy |
29,900
+8,500
| +40% | +$840K | 0.9% | 41 |
|
|
2017
Q3 | $2.56M | Buy |
21,400
+2,100
| +11% | +$252K | 0.78% | 46 |
|
|
2017
Q2 | $1.69M | Sell |
19,300
-10,300
| -35% | -$900K | 0.48% | 53 |
|
|
2017
Q1 | $1.1M | Buy |
+29,600
| New | +$1.1M | 0.35% | 64 |
|
|
2015
Q3 | – | Sell |
-3,700
| Closed | -$432K | – | 89 |
|
|
2015
Q2 | $432K | Buy |
3,700
+1,400
| +61% | +$163K | 0.13% | 89 |
|
|
2015
Q1 | $543K | Sell |
2,300
-600
| -21% | -$142K | 0.18% | 82 |
|
|
2014
Q4 | $549K | Buy |
+2,900
| New | +$549K | 0.22% | 79 |
|